Rapid Test for COPD Exacerbations Begins Study
ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
ProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
An American Lung Association initiative aims to educate patients and healthcare providers about investigational treatment options for severe and rare lung diseases.
A US study is evaluating a drug-coated balloon designed to improve outcomes for chronic rhinosinusitis patients undergoing sinus surgery.
A study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.
A collaboration between Jiva.ai and Aevice Health has developed a predictive model that identifies potential asthma exacerbations up to 72 hours in advance.